PHARMA-TRADE A/S — Credit Rating and Financial Key Figures

CVR number: 87339815

Skaaremosevej 11-14, Blistrup 3230 Græsted

rsa@persano.dk

Income statement (mDKK)

	2019	2020	2021	2022	2023
Fiscal period length	12	12	12	12	12
Net sales	323.04	334.73	366.15	337.74	374.75
Other operating income	0.16	0.13	0.07	0.06	0.00
Costs of manufacturing	- 229.62	- 229.49	- 252.67	- 245.89	- 274.80
Gross profit	93.42	105.23	113.48	91.85	99.95
Costs of management	-47.16	-46.64	-50.30	-51.15	-51.22
Costs of distribution	-4.84	-3.12	-3.73	-4.08	-4.04
EBIT	41.57	55.61	59.52	36.67	44.69
Other financial income	0.07	0.06	0.11	0.28	1.16
Other financial expenses	-2.65	-2.68	-2.42	-2.14	-1.80
Reduction non-current investment assets	-0.21	-0.21	-0.21	-0.21	-0.21
Pre-tax profit	38.78	52.78	57.00	34.59	43.85
Income taxes	-8.61	-11.70	-10.56	-6.58	-9.49
Net earnings	30.17	41.08	46.44	28.01	34.35

	2019	2020	2021	2022	2023
Goodwill	0.84	0.63	0.42	0.21
Intangible assets total	0.84	0.63	0.42	0.21
Land and waters	74.61	80.72	76.65	72.78	69.07
Buildings	34.18	34.84	37.32	37.13	36.00
Machinery and equipment	2.12	2.40	1.78	1.54	1.92
Advance payments and construction in progress	1.74	3.62	3.32	3.99	2.64
Tangible assets total	112.65	121.58	119.07	115.44	109.63
Other receivables	0.11	0.17	0.17	0.17	4.73
Investments total	0.11	0.17	0.17	0.17	4.73
Non-current loans receivable	0.58	0.46	0.53	0.67	0.66
Non-current other receivables				0.52	0.06
Long term receivables total	0.58	0.46	0.53	1.19	0.73
Semifinished products	3.62	4.67	4.53	5.11	5.79
Raw materials and consumables	56.40	58.23	65.61	79.82	69.92
Finished products/goods	17.16	16.84	17.05	19.14	22.77
Inventories total	77.17	79.75	87.19	104.08	98.48
Current trade debtors	69.87	74.78	77.54	87.06	76.70
Prepayments and accrued income		0.36	0.41	0.26	1.27
Current other receivables	0.13	0.13	0.09	0.06	0.42
Current deferred tax assets	0.11	0.78	1.52	1.80
Short term receivables total	70.12	76.04	79.57	89.19	78.39
Cash and bank deposits	62.49	69.47	54.79	14.16	49.76
Cash and cash equivalents	62.49	69.47	54.79	14.16	49.76
Balance sheet total (assets)	323.95	348.09	341.73	324.43	341.73

	2019	2020	2021	2022	2023
Share capital	3.00	3.00	3.00	3.00	3.00
Asset revaluation reserve	15.28	21.74	20.59	19.46	18.34
Shares repurchased	30.00	40.00	40.00	20.00	30.00
Other reserves		-0.03	2.75	10.39	0.39
Retained earnings	136.51	127.42	129.65	157.22	156.35
Profit of the financial year	30.17	41.08	46.44	28.01	34.35
Shareholders equity total	214.97	233.22	242.44	238.09	242.44
Provisions	13.32	15.44	15.07	14.78	14.50
Non-current loans from credit institutions	46.37	43.02	39.65	36.45	34.12
Non-current other liabilities	14.49	14.52	10.96
Non-current deferred tax liabilities				1.68	2.59
Non-current liabilities total	60.86	57.55	50.60	38.14	36.71
Current loans from credit institutions	3.35	3.35	3.36	3.24	2.79
Advances received	0.02	0.56	0.30		0.24
Current trade creditors	22.63	22.83	22.04	26.84	28.77
Short-term deferred tax liabilities					0.26
Other non-interest bearing current liabilities	8.81	15.16	7.91	3.35	2.51
Current liabilities total	34.81	41.89	33.62	33.43	34.57
Balance sheet total (liabilities)	323.95	348.09	341.73	324.43	328.21

Try the full version of our system for free

... and more!

No registration needed.